Assembly Biosciences (ASMB) Change in Acquisitions & Divestments (2015 - 2026)

Assembly Biosciences' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $57.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 117.92% year-over-year to $57.6 million; the TTM figure through Mar 2026 stood at $147.6 million (up 8.42% YoY), while the FY2025 annual figure was $116.4 million, down 10.92% from the prior year.
• Change in Acquisitions & Divestments was $57.6 million for Q1 2026 at Assembly Biosciences, up from $32.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $61.0 million in Q4 2022 to a low of $5.0 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $26.9 million across 5 years, with a median of $22.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments slumped 94.79% in 2022, then soared 192.9% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $61.0 million in 2022, then sank by 69.34% to $18.7 million in 2023, then jumped by 82.89% to $34.2 million in 2024, then slipped by 4.09% to $32.8 million in 2025, then surged by 75.61% to $57.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $57.6 million (Q1 2026), $32.8 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.